Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Part D Rebate Pass-Throughs To Beneficiaries Is 'On The Table'

Executive Summary

Lilly CEO David Ricks reflects on the state of play on drug pricing issues on Capitol Hill and in the Administration and the challenges he sees ahead.

Advertisement

Related Content

Medicare May Require Part D Plans To Provide Point-of-Sale Rebates
CMS Proposal On Part D May Address Drug Costs, But Will It Target Prices?
Medicare Part D Premiums Dip As Rebates Grow Faster Than Drug Costs To Plans
Point-Of-Sale Rebates In Part D: Study Highlights Trade-Offs For Medicare
Trump Exec Order On Drug Costs: Seeking To Balance Access, Innovation
CVS Point-Of-Sale Rebate Program Adopted By 'Several' Payers
Trump Drug Pricing Plan May Include Rebate Pass-Through Push – Novartis CEO

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS121187

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel